Objective: A Hydatidiform mole is characterized by a hydropic swelling of the chorionic villi and trophoblastic proliferation. It is classified as a complete hydatidiform mole and partial hydatidiform mole on the basis of histopathological features and karyotype. Women of both extreme of reproductive age are most vulnerable. Untreated molar pregnancies almost always cause uterine bleeding that varies spotting to profuse hemorrhage. This study was conducted to calculate incidence of molar pregnancy, associated demographic factors and to analyze the various aspects of molar pregnancy at our hospital.

Materials and Methods: A retrospective study was carried out for over a period of two years from April 2015 to March 2017 in the Department of Obstetrics and Gynecology at S. K. Medical College, Muzaffarpur, Bihar to calculate the incidence of molar pregnancy, to study the associated demographic factors and to analyze the various aspects of molar pregnancy at our hospital. All the relevant data were collected from hospital records and departmental registers. Collected data were computed and analyzed statistically.

Results: A total of 37 cases of molar pregnancies were recorded for the period of two years. During this study period, the total number of deliveries was 18,143. Hence the incidence of molar pregnancy in our study is 0.815 in 400 deliveries. 64.86% cases were of age group 20-30 years. Uterine size larger as compared to gestation age was observed in 78.37% cases. Serum β hCG level were between 50000-100000 in 59.46% of cases. 75.67% cases were presented with a gestational age of 10-20 weeks.

Conclusion: Early detection of high risk pregnancies and their prompt management and referral is necessary. Early detection by ultrasonography and serum β hCG value is necessary for proper management of molar pregnancies. Prophylactic chemotherapy is also of significance in management and to prevent further recurrence of molar pregnancy.

Keywords: Complete mole, Hemorrhage, Hydatidiform mole, Invasive mole, Partial mole.

1. Benirschke K, Burton GJ, Baergen RN (eds): Molar pregnancies. In Pathology of the Human Placenta, 6^th New York, Springer, 2012, p 687
2. Sebire NJ, Lindsay I, Fisher RA: Overdiagnosis of complete and partial hydatidiform mole in tubal ectopic pregnancies. Int J Gynecol Pathol 24(3):260, 2005
3. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediat Develpo Pathol. 2003 Jan1;6(1):69-77.
4. Seckl MJ, Dhillon T, Dancey G, Foskett M, Paradinas FJ, Rees HC, et al. Increased gestational age at evacuation of a complete hydatidiform mole: does it correlate with increased risk of requiring chemotherapy?. J Reprod Med. 2004;49(7):527-30
5. Khoo SK, Siddhu M, Bartz D, Persistence and malignant squeal of gestational trophoblastic disease, clinical presentation, diagnosis, treatment and outcome. Aust NZJ Obstet Gynecol. 2010:50:81-6
6. Newland SES, Holden L, Seckl M, Strickland S, Rustin G. Management of brain metastasis in patients with high risk gestational trophoblastic disease with risk gestational trophoblastic diseases. Reprod Med. 2002;47:465-71
7. Altman AD, Bently B, Murray S, et al: Maternal age-related rate of gestational trophoblastic disease. Obstet Gynecol 112:244, 2008
8. Sebire NJ, Foskett M, Fisher RA, et al: Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. Br J Obstet Gynaecol 109:99, 2002a
9. Garrett LA, Garner EIO, Feltmate CM, et al: Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med 53:481, 2008
10. Berkowitz RS, Im SS, Bernstein MR, et al: Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 43:81, 1998
11. D’Couth S, et al.(2013). A Retrospective Study of Gestational Trophoblastic Neoplasia in a Tertiary Care Centre. J. of Evolution of Medical and Dental Sciences, 2(31):5813-5819
12. Kerkmeijer LG, Massuger LF, Ten Kate-Booiji MJ, et al: Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol 113:326, 2009
13. Mangili G, Garavaglia E, Cavoretto P, et al: Clinical presentation of hydatidiform mole in northern Italy: has it changed in the last 20 years? Am J Obster Gynecol 198(3):302.e1, 2008
14. Niemann I, Petersen LK, Hansen ES, et al: Differences in current clinical features of diploid and triploid hydatidiform mole. BJOG 114:1273, 2007a
15. Lakra P, Sangwan V, Siwach S, Kansal R, Mahendru R, Sharma A. Outcome of gestational trophoblastic disease in a rural tertiary centre of Haryana, India. Int J Reprod Contracept Obstet Gynecol 2017;6:271-5
16. Gemer O, Segal S, Kopmar A, et al: The current clinical presentation of complete molar pregnancy. Arch Gynecol Obstet 264(1):33, 2000
17. Fowler DJ, Lindsay I, Seckl MJ, et al: Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 27(1):56, 2006
18. Paradinas FJ, Browne P, Fisher RA, et al: A clinical, histological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortion. Histopathology 28(2):101, 1996.

Amrita Pritam­­­­­­­­

Senior Resident, Department of Obs & Gynae, Sri Krishna Medical College & Hospital, Muzaffarpur, Bihar